Noam Chomsky and Robert Pollin, authors of new book Climate Crisis and the Global Green New Deal, join us to talk about the climate emergency, how it can be solved, and the forthcoming US election.
Peter Hotez joins us to talk vaccine progress and how science needs to communicate in the USA, and philosopher of science Cailin O'Connor discusses our understanding of theories, facts, and how misinformation spreads.
In a special episode for Peer Review Week 21-25 September, editor-in-chief of The Lancet Richard Horton joins us to discuss the past, present, and future of scientific publishing in light of COVID-19.
In this episode we speak to Prof. Arne Akbar, President of the British Society for Immunology, about the most recent research on COVID-19 and our current understanding of the long-term effects, and Dr. Jenna Lester, founder of San Francisco's Skin of Colour Clinic, joins us to talk about the problems people of colour have receiving dermatological treatment.
We ask Prof. Gill Livingston how up to 40% of dementia cases can be prevented, and Dr. Saskia Osendarp tells us how COVID-19 looks set to undo two decades of progress on child malnutrition.
This week we talk with Prof. Kenji Shibuya, Director of the King's Institute for Population Health, about mask-wearing and pandemic response in Japan, and The Lancet Psychiatry Editor-in-Chief Dr. Niall Boyce walks us through the problems of institutionalised care for children.
Richard Horton updates us on a leap forward in the Oxford and China vaccine progress, we talk viral transmission on public transport, and Kathleen O'Reilly explains how scientists create and test models.
How many people have COVID-19 antibodies? What does having antibodies mean? Rosanna Peeling explains the latest, and we're joined by Ashley McMullen from the Nocturnists podcast to chat about her experiences and her new series, Black Voices in Healthcare.
In a bumper episode of The Lancet Voice we speak with Kalipso Chalkidou about COVID-19 vaccine access for low and middle-income countries, we hear about why insulin costs so much in the US and what can be done about it, and we talk breakthroughs in treating venomous snakebites, one of the world's biggest hidden health problems.
What are cytokine storms, and how do they affect patients? Our editors speak with immunologist Scott Canna and rheumatologist Rachel Tattersall to help understand this condition.
The Lancet Voice chats with Holger Schünemann and Derek Chu, authors of new research on physical distancing, face masks, and eye protection, to find out the best approach to these vital virus control methods.
Philosopher Philippe Van Parijs discusses the state's stake in its citizens' health and the expansion of the role of the state during and after the coronavirus pandemic.
Yap Boum of Médecins Sans Frontières and Zoe Mullan, Editor-in-Chief of The Lancet Global Health, discuss the particular issues facing Sub-Saharan Africa.
Does infection confer immunity? Is the virus mutating? How long could immunity last? Arne Akbar, Professor of Immunology at UCL, answers some of the big questions surrounding the pandemic.
Another special episode of The Lancet Voice speaks with a doctor about the outbreak of Kawasaki-like disease in children following SARS-CoV-2 infection.
Another special COVID-19 episode of The Lancet Voice looks into using the blood of recovered patients to treat serious cases. Julie Stacey speaks with Prof. Liise-Anne Pirofski of the Albert Einstein College of Medicine.
How are staff being reassigned? What have their experiences been like? A special episode speaks with NHS doctors to ask about life during COVID-19 in the UK.
A special episode speaks with Professor Hilary Pinnock to examine the current evidence and advice for patients with asthma and clinicians caring for them.
Much of the discourse on COVID-19 has been about older people being at high risk. The Lancet Voice speaks to Professor Thomas Scharf, president of The British Society of Gerontology about how COVID-19 is affecting age discrimination and loneliness.
How does misinformation start? Why is it spread? What is being done about it? What is “behavioural fatigue”? The Lancet Voice speaks with Sander van der Linden, director of the Cambridge Social Decision-Making Laboratory, to find out more.
A special episode of The Lancet Voice looks into the lack of personal protective equipment, or PPE, for healthcare workers in the NHS.
How does COVID-19 affect pregnancy? In this special episode of The Lancet Voice, Lancet editors speak to frontline staff around the world to see how approaches have evolved.
Caroline Criado Perez discusses how cardiovascular health in women has been ignored by medicine, a doctor in Wuhan shares first-hand COVID-19 experiences, and NASA scientists explain how life on Mars might affect health on Earth.
In a packed pilot episode of The Lancet Voice, our EBioMedicine Editor-in-Chief, Julie Stacey, reports on how SARS changed our approach to treating and tracking coronaviruses, The Lancet's Editor-In-Chief, Richard Horton chats with Ben Goldacre about researchers owing the US Government $7bn, and we discuss the planetary health diet – what’s the real link between food and the climate?
